Free Trial
NYSE:GEN

Genesis Healthcare (GEN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$25.04
$25.77
50-Day Range
$0.18
$0.60
52-Week Range
$0.40
$1.37
Volume
2.53 million shs
Average Volume
4.10 million shs
Market Capitalization
$16.46 billion
P/E Ratio
28.61
Dividend Yield
1.94%
Price Target
$27.20

Genesis Healthcare MarketRank™ Stock Analysis

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
5.6% Upside
$27.20 Price Target
Short Interest
N/A
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.00mentions of Genesis Healthcare in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.52%
From $1.63 to $1.72 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.72 out of 5 stars

Business Services Sector

277th out of 301 stocks

Prepackaged Software Industry

183rd out of 197 stocks

GEN stock logo

About Genesis Healthcare Stock (NYSE:GEN)

Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.

GEN Stock News Headlines

Wanted Dead: Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.
Wanted Dead: Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.
See More Headlines
Receive GEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/12 Dividend
5/17/2024
Dividend Payable
6/12/2024
Last Earnings
8/01/2024
Ex-Dividend for 9/11 Dividend
8/19/2024
Today
8/22/2024
Dividend Payable
9/11/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Employees
2,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$27.20
High Stock Price Target
$29.00
Low Stock Price Target
$25.00
Potential Upside/Downside
+5.6%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$836 million
Pretax Margin
23.69%

Debt

Sales & Book Value

Annual Sales
$2.80 billion
Cash Flow
$3.06 per share
Book Value
($0.16) per share

Miscellaneous

Free Float
618,038,000
Market Cap
$16.46 billion
Optionable
Optionable
Beta
0.84
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Robert H. Fish (Age 70)
    CEO & Director
    Comp: $411.5k
  • Mr. Thomas DiVittorio (Age 53)
    Exec. VP & CFO
    Comp: $565k
  • Mr. Paul David Bach (Age 62)
    COO & Exec. VP
    Comp: $630k
  • Mr. Stephen Scott Young (Age 49)
    Chief Accounting Officer & Treasurer
  • Mr. Richard L. Castor (Age 66)
    Chief Information Officer & Sr. VP
  • Mr. James W. Tabak (Age 62)
    Sr. VP of Admin. & Gov. Affairs
  • Ms. Lori Mayer
    VP of Investor Relations, Brand Management & Marketing Communications
  • Mr. Michael Scott Sherman (Age 52)
    Sr. VP, Gen. Counsel, Sec. & Assistant Treasurer
  • Mr. Larry Baider
    Sr. VP of People Strategy & Operations
  • Dr. JoAnne Susan Reifsnyder R.N. (Age 62)
    Ph.D., Ph.D., ACHPN, MSN, MBA, RN, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer

GEN Stock Analysis - Frequently Asked Questions

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare, Inc. (NYSE:GEN) announced its quarterly earnings data on Thursday, August, 1st. The company reported $0.53 earnings per share for the quarter, meeting the consensus estimate of $0.53. Genesis Healthcare's revenue for the quarter was up 2.3% compared to the same quarter last year.

Is Genesis Healthcare doing a stock buyback?

Genesis Healthcare's board approved a stock buyback plan on Thursday, May 9th 2024, which allows the company to buy back $3,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 23.1% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's leadership believes its shares are undervalued.

Who are Genesis Healthcare's major shareholders?

Top institutional shareholders of Genesis Healthcare include LSV Asset Management (1.15%), Bank of New York Mellon Corp (0.84%), Dimensional Fund Advisors LP (0.78%) and Hsbc Holdings PLC (0.31%).
View institutional ownership trends
.

What other stocks do shareholders of Genesis Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Flaherty & Crumrine Preferred Securities Income Fund (FFC), Vaxart (VXRT), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), Amarin (AMRN) and Government Properties Income Trust (GOV).

This page (NYSE:GEN) was last updated on 8/22/2024 by MarketBeat.com Staff

From Our Partners